Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+60.0%
5Y CAGR+42.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+60.0%/yr
vs +64.2%/yr prior
5Y CAGR
+42.3%/yr
Recent acceleration
Acceleration
-4.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.20B | +79.0% |
| 2024 | $671.77M | +76.6% |
| 2023 | $380.50M | +29.6% |
| 2022 | $293.57M | +21.1% |
| 2021 | $242.48M | +17.8% |
| 2020 | $205.85M | +117.0% |
| 2019 | $94.86M | +135.0% |
| 2018 | $40.36M | +26.9% |
| 2017 | $31.81M | +27.3% |
| 2016 | $24.98M | - |